Cargando…

Oral and Intraperitoneal Administration of Quercetin Decreased Lymphocyte DNA Damage and Plasma Lipid Peroxidation Induced by TSA In Vivo

Our previous study showed that quercetin enhances the anticancer effect of trichostatin A (TSA) in xenograft mice given quercetin intraperitoneally (10 mg/kg, 3 times/week). Herein, we investigate whether quercetin administered orally exerts such an effect and prevents the cytotoxic side effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Shu-Ting, Lin, Yi-Chin, Chuang, Cheng-Hung, Shiau, Rong-Jen, Liao, Jiunn-Wang, Yeh, Shu-Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017723/
https://www.ncbi.nlm.nih.gov/pubmed/24868531
http://dx.doi.org/10.1155/2014/580626
_version_ 1782479999679332352
author Chan, Shu-Ting
Lin, Yi-Chin
Chuang, Cheng-Hung
Shiau, Rong-Jen
Liao, Jiunn-Wang
Yeh, Shu-Lan
author_facet Chan, Shu-Ting
Lin, Yi-Chin
Chuang, Cheng-Hung
Shiau, Rong-Jen
Liao, Jiunn-Wang
Yeh, Shu-Lan
author_sort Chan, Shu-Ting
collection PubMed
description Our previous study showed that quercetin enhances the anticancer effect of trichostatin A (TSA) in xenograft mice given quercetin intraperitoneally (10 mg/kg, 3 times/week). Herein, we investigate whether quercetin administered orally exerts such an effect and prevents the cytotoxic side effects of TSA. We found that quercetin given orally (20 and 100 mg/kg, 3 times/week) failed to enhance the antitumor effect of TSA although it increased the total quercetin concentration more than quercetin administered intraperitoneally in the plasma. The compound quercetin-3-glucuronide (Q3G) increased the most. However, quercetin administered intraperitoneally increased the total quercetin level in tumor tissues more than oral quercetin. Oral and intraperitoneal administration of quercetin similarly decreased lymphocyte DNA damage and plasma lipid peroxidation level induced by TSA. Furthermore, we found that the enhancing effect of Q3G on the antitumor effect of TSA and the incorporation of Q3G was less than that of quercetin in A549 cells. However, we found that A549 cells possessed the ability to convert Q3G to quercetin. In conclusion, different from quercetin administered intraperitoneally, quercetin administered orally failed to enhance the antitumor effect of TSA because of its metabolic conversion. However, it prevented TSA-induced DNA damage and lipid peroxidation.
format Online
Article
Text
id pubmed-4017723
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40177232014-05-27 Oral and Intraperitoneal Administration of Quercetin Decreased Lymphocyte DNA Damage and Plasma Lipid Peroxidation Induced by TSA In Vivo Chan, Shu-Ting Lin, Yi-Chin Chuang, Cheng-Hung Shiau, Rong-Jen Liao, Jiunn-Wang Yeh, Shu-Lan Biomed Res Int Research Article Our previous study showed that quercetin enhances the anticancer effect of trichostatin A (TSA) in xenograft mice given quercetin intraperitoneally (10 mg/kg, 3 times/week). Herein, we investigate whether quercetin administered orally exerts such an effect and prevents the cytotoxic side effects of TSA. We found that quercetin given orally (20 and 100 mg/kg, 3 times/week) failed to enhance the antitumor effect of TSA although it increased the total quercetin concentration more than quercetin administered intraperitoneally in the plasma. The compound quercetin-3-glucuronide (Q3G) increased the most. However, quercetin administered intraperitoneally increased the total quercetin level in tumor tissues more than oral quercetin. Oral and intraperitoneal administration of quercetin similarly decreased lymphocyte DNA damage and plasma lipid peroxidation level induced by TSA. Furthermore, we found that the enhancing effect of Q3G on the antitumor effect of TSA and the incorporation of Q3G was less than that of quercetin in A549 cells. However, we found that A549 cells possessed the ability to convert Q3G to quercetin. In conclusion, different from quercetin administered intraperitoneally, quercetin administered orally failed to enhance the antitumor effect of TSA because of its metabolic conversion. However, it prevented TSA-induced DNA damage and lipid peroxidation. Hindawi Publishing Corporation 2014 2014-04-23 /pmc/articles/PMC4017723/ /pubmed/24868531 http://dx.doi.org/10.1155/2014/580626 Text en Copyright © 2014 Shu-Ting Chan et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Chan, Shu-Ting
Lin, Yi-Chin
Chuang, Cheng-Hung
Shiau, Rong-Jen
Liao, Jiunn-Wang
Yeh, Shu-Lan
Oral and Intraperitoneal Administration of Quercetin Decreased Lymphocyte DNA Damage and Plasma Lipid Peroxidation Induced by TSA In Vivo
title Oral and Intraperitoneal Administration of Quercetin Decreased Lymphocyte DNA Damage and Plasma Lipid Peroxidation Induced by TSA In Vivo
title_full Oral and Intraperitoneal Administration of Quercetin Decreased Lymphocyte DNA Damage and Plasma Lipid Peroxidation Induced by TSA In Vivo
title_fullStr Oral and Intraperitoneal Administration of Quercetin Decreased Lymphocyte DNA Damage and Plasma Lipid Peroxidation Induced by TSA In Vivo
title_full_unstemmed Oral and Intraperitoneal Administration of Quercetin Decreased Lymphocyte DNA Damage and Plasma Lipid Peroxidation Induced by TSA In Vivo
title_short Oral and Intraperitoneal Administration of Quercetin Decreased Lymphocyte DNA Damage and Plasma Lipid Peroxidation Induced by TSA In Vivo
title_sort oral and intraperitoneal administration of quercetin decreased lymphocyte dna damage and plasma lipid peroxidation induced by tsa in vivo
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017723/
https://www.ncbi.nlm.nih.gov/pubmed/24868531
http://dx.doi.org/10.1155/2014/580626
work_keys_str_mv AT chanshuting oralandintraperitonealadministrationofquercetindecreasedlymphocytednadamageandplasmalipidperoxidationinducedbytsainvivo
AT linyichin oralandintraperitonealadministrationofquercetindecreasedlymphocytednadamageandplasmalipidperoxidationinducedbytsainvivo
AT chuangchenghung oralandintraperitonealadministrationofquercetindecreasedlymphocytednadamageandplasmalipidperoxidationinducedbytsainvivo
AT shiaurongjen oralandintraperitonealadministrationofquercetindecreasedlymphocytednadamageandplasmalipidperoxidationinducedbytsainvivo
AT liaojiunnwang oralandintraperitonealadministrationofquercetindecreasedlymphocytednadamageandplasmalipidperoxidationinducedbytsainvivo
AT yehshulan oralandintraperitonealadministrationofquercetindecreasedlymphocytednadamageandplasmalipidperoxidationinducedbytsainvivo